BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 25497688)

  • 1. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
    Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R
    Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.
    Anandhan A; Lei S; Levytskyy R; Pappa A; Panayiotidis MI; Cerny RL; Khalimonchuk O; Powers R; Franco R
    Mol Neurobiol; 2017 Jul; 54(5):3825-3842. PubMed ID: 27324791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.
    Navarro-Yepes J; Anandhan A; Bradley E; Bohovych I; Yarabe B; de Jong A; Ovaa H; Zhou Y; Khalimonchuk O; Quintanilla-Vega B; Franco R
    Mol Neurobiol; 2016 Oct; 53(8):5229-51. PubMed ID: 26409479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF compromises lysosome acidification and reduces α-synuclein degradation via autophagy in dopaminergic cells.
    Wang MX; Cheng XY; Jin M; Cao YL; Yang YP; Wang JD; Li Q; Wang F; Hu LF; Liu CF
    Exp Neurol; 2015 Sep; 271():112-21. PubMed ID: 26001614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A30P mutant α-synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons.
    Lei Z; Cao G; Wei G
    Cell Death Dis; 2019 Feb; 10(2):133. PubMed ID: 30755581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein Enhances Cadmium Uptake and Neurotoxicity via Oxidative Stress and Caspase Activated Cell Death Mechanisms in a Dopaminergic Cell Model of Parkinson's Disease.
    Chong W; Jiménez J; McIIvin M; Saito MA; Kwakye GF
    Neurotox Res; 2017 Aug; 32(2):231-246. PubMed ID: 28353032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
    Caudal D; Alvarsson A; Björklund A; Svenningsson P
    Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells.
    Wang K; Huang J; Xie W; Huang L; Zhong C; Chen Z
    Diagn Pathol; 2016 Jan; 11():15. PubMed ID: 26822891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin-interacting protein induced α-synuclein accumulation via inhibition of autophagic flux: Implications for Parkinson's disease.
    Su CJ; Feng Y; Liu TT; Liu X; Bao JJ; Shi AM; Hu DM; Liu T; Yu YL
    CNS Neurosci Ther; 2017 Sep; 23(9):717-723. PubMed ID: 28755477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and Cu+/2+ can induce oligomerization of α-synuclein in the absence of oxygen: Two types of oligomerization mechanisms for α-synuclein and related cell toxicity studies.
    Ha Y; Yang A; Lee S; Kim K; Liew H; Lee SH; Lee JE; Lee HI; Suh YH; Park HS; Churchill DG
    J Neurosci Res; 2014 Mar; 92(3):359-68. PubMed ID: 24288134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
    Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
    PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
    Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
    Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons.
    Henderson MX; Peng C; Trojanowski JQ; Lee VMY
    Acta Neuropathol Commun; 2018 May; 6(1):45. PubMed ID: 29855356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.